Baker Avenue Asset Management, LP Sarepta Therapeutics, Inc. Transaction History
Baker Avenue Asset Management, LP
- $5.03 Billion
- Q3 2025
A detailed history of Baker Avenue Asset Management, LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 62,063 shares of SRPT stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
62,063Holding current value
$1.49 Million% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
449Shares Held
82.1MCall Options Held
5.6MPut Options Held
4.17M-
Black Rock Inc. New York, NY10.3MShares$248 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$220 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$113 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$108 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$60.8 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...